Allogene Therapeutics, Inc. (ALLO) Insider Trading

Over the last 3 months, ALLO insiders made 0 open-market buys and 1 sale, a net sale of -$22K (SEC Form 4). Over the last 6 months, 132 institutions increased and 92 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
1
Net (3m)
-$22.1K
Insider trades by month Buys Sells
Oct
Nov
Jan
Feb
Mar
Apr
Context3-month price -14.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 23, 2026Barrett Elizabeth A.directorGrant95,400—
Jun 23, 2026WITTE OWEN N.directorGrant95,400—
Jun 23, 2026SATO VICKI LdirectorGrant95,400—
Jun 23, 2026Mayo StephendirectorGrant144,400$2.00
Jun 23, 2026MESSEMER DEBORAH M.directorGrant95,400—
Jun 23, 2026Kazam Joshua AdirectorGrant95,400—
Jun 23, 2026Kazam Joshua AdirectorOption47,700—
Jun 23, 2026Humer Franz BdirectorGrant95,400—
Apr 23, 2026Yoshiyama Annieofficer: SVP, FinanceSell9,586$2.31
Apr 2, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell2,867$2.50
Mar 18, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell4,835$2.47
Mar 18, 2026Chang David Ddirector, officer: President and CEOSell47,763$2.47
Mar 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,132$2.60
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceGrant50,827—
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceGrant179,691$1.87
Feb 4, 2026Yoshiyama Annieofficer: SVP, FinanceSell4,167$1.72
Feb 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerGrant373,757$1.87
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DGrant718,763$1.87
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DSell35,700$1.77
Feb 4, 2026Roberts Zacharyofficer: EVP of R&DGrant203,307—
Feb 4, 2026Belldegrun AriedirectorGrant929,913$1.87
Feb 4, 2026Belldegrun AriedirectorGrant263,033—
Feb 4, 2026Chang David Ddirector, officer: President and CEOSell95,269$1.80
Feb 4, 2026Chang David Ddirector, officer: President and CEOGrant1,387,931$1.87
Feb 4, 2026Chang David Ddirector, officer: President and CEOGrant392,586—
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERSell24,001$1.76
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERGrant539,072$1.87
Feb 4, 2026Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERGrant152,480—
Feb 4, 2026Douglas Earl Martinofficer: SVP, General CounselSell22,900$1.76
Feb 4, 2026Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,549$1.73

Source: ALLO SEC Form 4 filings, latest Jun 23, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ALLO positions over the last 6 months (SEC Form 13F).

Increased
132
New positions
77
Reduced
92
Sold out
36
Largest moves
InstitutionActionSharesFiled
PFIZER INCUnchanged22.0MMay 12, 2026
PFIZER INCUnchanged22.0MFeb 12, 2026
BLACKROCK, INC.Increased19.1MMay 13, 2026
TPG GP A, LLCUnchanged18.7MFeb 13, 2026
TPG GP A, LLCUnchanged18.7MMay 15, 2026
BLACKROCK, INC.Increased17.7MFeb 12, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position13.8MMay 15, 2026
CITADEL ADVISORS LLCReduced12.1MFeb 17, 2026
VANGUARD GROUP INCIncreased9.3MJan 29, 2026
STATE STREET CORPIncreased8.7MMay 15, 2026
PRIMECAP MANAGEMENT CO/CA/Increased8.4MMay 11, 2026
PRIMECAP MANAGEMENT CO/CA/Increased8.1MFeb 11, 2026
WOODLINE PARTNERS LPIncreased7.0MMay 15, 2026
CITADEL ADVISORS LLCReduced6.9MMay 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased5.4MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to ALLO overview (price, financials, earnings)